News

EuroPCR: New Sapien 3 TAVI valve findings show ‘wow’ factor

Publish date: June 8, 2015

 

AT EUROPCR 2015

References

The Sapien 3 studies are sponsored by Edwards Lifesciences. Dr. Vahanian is a consultant to the company.

bjancin@frontlinemedcom

Pages

Recommended Reading

Carotid artery stenosis guidelines need modernizing
MDedge Cardiology
AATS: Spare the aortic valve when possible during aortic root replacements
MDedge Cardiology
The ‘threats and obstacles’ facing TMVR
MDedge Cardiology
Point/Counterpoint: Mechanical vs. biological mitral valve for 50-year-old with rheumatic disease
MDedge Cardiology
Hemodynamics after MVR better than annuloplasty's
MDedge Cardiology
Ablation may raise risk for later myectomy
MDedge Cardiology
Cardiac surgeons defy guidelines for severe disease
MDedge Cardiology
Traditional diagnostic criteria miss OSA in coronary artery disease patients
MDedge Cardiology
TAVI embolic protection device shows favorable safety, efficacy
MDedge Cardiology
EuroPCR: Which TAVI vascular closure device is safest?
MDedge Cardiology

Related Articles